Long-Term Health Impacts of COVID-19: A Growing Concern
New research suggests that even mild COVID-19 infections can weaken the immune system, increasing the risk of other infections like mononucleosis, commonly known as “mono” or kissing disease. A recent study following nearly ten million people in Sweden between 2020 and 2022 has revealed a clear link between COVID-19 and an increased incidence of mono.
COVID-19 and Epstein-Barr Virus (EBV)
The study, conducted by researchers at Örebro University, divided participants into three groups: those who never had COVID-19, those with mild infections, and those requiring hospitalization. Results indicated that even individuals with mild COVID-19 cases experienced immune system suppression and a higher risk of contracting Epstein-Barr virus (EBV), the virus that causes mononucleosis.
“We were surprised to find that even those who tested positive for COVID-19 without experiencing severe symptoms were affected by a weakened immune system and a higher risk of, for example, mononucleosis,” explains Snieguole Vingeliene, a researcher in medicine and epidemiology at Örebro University.
The Rise in Mononucleosis Cases
Researchers focused on individuals hospitalized with mononucleosis, acknowledging that many cases are mild enough to go unreported. This suggests the actual number of COVID-19 related mono cases is likely much higher than currently documented.
Approximately 90% of the Swedish population carries the Epstein-Barr virus, but most individuals remain asymptomatic. But, adults who contract mononucleosis can experience symptoms like sore throat, fatigue, and flu-like illness.
Young Adults at Higher Risk
The study highlighted a concerning trend: a significant proportion of participants were relatively young. This suggests that COVID-19 may have a more pronounced effect on the immune systems of younger individuals, specifically concerning their susceptibility to mononucleosis. This also raises the possibility of further health consequences emerging later in life.
Potential Link to Neurological Diseases
The Epstein-Barr virus has also been linked to multiple sclerosis (MS). While researchers haven’t established a direct correlation between COVID-19 and MS, they are concerned that the coronavirus could potentially increase the risk of developing MS and other serious neurological conditions in the long term.
“Although the risk is elevated, developing MS is still rare, affecting less than one in one hundred people. Anyone concerned should consult with a healthcare professional,” advises Vingeliene.
Did you grasp? The study analyzed data from a national register, providing a broad and representative sample of the Swedish population.
What Does This Mean for the Future?
The findings underscore the importance of continued monitoring of long-term health outcomes following COVID-19 infection. The potential for increased susceptibility to other infections, like mononucleosis, and the possible link to neurological diseases warrant further investigation.
FAQ
Q: Does having had COVID-19 mean I will definitely get mono?
A: No, it means your risk is increased, but it doesn’t guarantee you will contract the virus.
Q: Is there a way to protect myself from these long-term effects?
A: Maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help support your immune system.
Q: What should I do if I’m concerned about potential long-term health effects?
A: Consult with your healthcare provider to discuss your concerns and receive personalized advice.
Pro Tip: Staying up-to-date with recommended vaccinations, including those for COVID-19, can help reduce your risk of infection and potential long-term complications.
Explore more articles on long-term health impacts of COVID-19 here.
